Plant Medicine Expands into New Realms

If the 2020 US election demonstrated anything, it's the growing appetite for natural medicines like cannabis and fungi. The fact that Oregon's legalization of psychedelic mushrooms received more positive media attention than most other than any other state ballot measures voted on during the election says a lot about the direction Americans want to go in the coming years.

Riding this wave of excitement, Gennifer Murray sat down with Damon Michaels, Founder and Chief Operating Officer of Mydecine, to discuss a new approach to nature-sourced medicines through a pharmaceutical lens.  

The Wild West environment many remember from the early years of weed are now replaying among psychedelics. Even so, psychedelic and mushroom medicines seem to be moving much more quickly than cannabis ever did. Michaels and the team at Mydecine aim to lay a solid, methodical, and thoughtful foundation for robust research and development — and one which importantly paves the way for a "breakthrough" ruling by the Food and Drug Administration (FDA).